Ignite Creation Date:
2025-12-24 @ 5:30 PM
Ignite Modification Date:
2025-12-24 @ 5:30 PM
Study NCT ID:
NCT06792968
Status:
COMPLETED
Last Update Posted:
2025-04-13
First Post:
2025-01-20
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 5 mg/1000 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy 5 mg/1000 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany)
Sponsor:
Gedeon Richter Plc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-03-30
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-04-08
Completion Date Type:
ACTUAL
First Submit Date:
2025-01-20
First Submit QC Date:
None
Study First Post Date:
2025-01-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-10
Last Update Post Date:
2025-04-13
Last Update Post Date Type:
ACTUAL